Completed NA INTERVENTIONAL 2-arm NCT01972425

Biomarker-based Exclusion of VAP for Improved Antibiotic Stewardship (VAPRapid-2)

A Randomised Controlled Trial of Biomarker-based Exclusion of VAP to Improve Antibiotic Stewardship

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust

Conditions Ventilator-associated Pneumonia

Interventions Biomarker-based diagnostic

Updated 6 times since 2017 Last updated: Mar 27, 2017 Started: Oct 31, 2013 Primary completion: Sep 30, 2016 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Ventilator-associated Pneumonia and is currently completed. Newcastle-upon-Tyne Hospitals NHS Trust leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Apr 2017 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Apr 2017 [monthly]

Recruiting NA

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Newcastle-upon-Tyne Hospitals NHS Trust
Wellcome Trust

Data source: Newcastle-upon-Tyne Hospitals NHS Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ashington, United Kingdom , Belfast, United Kingdom , Birmingham, United Kingdom , Chester, United Kingdom , Coventry, United Kingdom , Dudley, United Kingdom , Edinburgh, United Kingdom , Gateshead, United Kingdom , Liverpool, United Kingdom , London, United Kingdom and 7 more locations